A team comprised of CEA-Leti Debiotech SA the Swedish Royal Institute of Technology (KTH) and Mecaplast SA is a finalist in the 2014 Medical Design Excellence Awards. They are nominated for a MEMS-based micro-needle that allows pain-free and precise injection of up to 0.5ml of vaccines and other medications in a few seconds.
The innovative DebioJectTM micro-needle injection device manufactured by Lausanne Switzerland-based Debiotech is designed to overcome the challenges of classic intradermal delivery techniques while improving accurate site-and-dose delivery. Unlike other intradermal delivery systems DebioJectTM is a hollow micro-needle with a unique side-protected delivery hole. By placing the hole on the side of the needle at a precise depth the skin can be punctured without coring and without removing any tissue.
http://www.debiotech.com/newsite/page/index.php?page=product_01&id=1&id_prod=47
Comentarios recientes